Search Results - "Verge, Denis Pere"
-
1
Totally implantable central venous access port infections in patients with digestive cancer: Incidence and risk factors
Published in American journal of infection control (01-12-2012)“…Background Central venous access port–related bloodstream infection (CVAP-BSI) is associated with morbidity and mortality in patients with cancer. This study…”
Get full text
Journal Article -
2
Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study
Published in Journal of clinical medicine (27-07-2020)“…(1) Background: Oxaliplatin is among the most neurotoxic anticancer drugs. Little data are available on the long-term prevalence and consequences of…”
Get full text
Journal Article -
3
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
Published in Frontiers in pharmacology (04-11-2021)“…Oxaliplatin, a pivotal drug in the management of colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN) in a third of cancer survivors…”
Get full text
Journal Article -
4
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Published in The New England journal of medicine (12-05-2011)“…In this study, a four-drug combination chemotherapy regimen was associated with objective responses in more than 30% of patients and increased survival by more…”
Get full text
Journal Article -
5
Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life
Published in Supportive care in cancer (01-07-2024)“…Purpose Sensory chemotherapy-induced peripheral neuropathy (CIPN) is well-recognized, but motor CIPN remains understudied. This secondary analysis focused on…”
Get full text
Journal Article -
6
Feasibility of preoperative and postoperative chemoradiotherapy in gastric adenocarcinoma. Two phase II studies done in parallel. Fédération Francophone de Cancérologie Digestive 0308
Published in European journal of cancer (1990) (01-04-2014)“…Abstract Background For resectable gastric cancer, both postoperative chemoradiotherapy and perioperative chemotherapy demonstrate high-level evidence for…”
Get full text
Journal Article -
7
-
8
Triple-A syndrome : A rare etiology of adult achalasia
Published in Digestive diseases and sciences (01-03-2005)Get full text
Journal Article -
9
Prospective Evaluation of the Automatic Location System During Capsule Endoscopy Examination of the Small Intestine
Published in Gastrointestinal endoscopy (01-04-2005)Get full text
Journal Article -
10
Manifestations anorectales, en rapport avec un lymphome de Burkitt associé au virus Epstein Barr, chez une malade immunocompétente
Published in Gastroentérologie clinique et biologique (01-04-2007)“…Nous rapportons l’observation d’une femme, âgée de 23 ans, d’origine caucasienne, immunocompétente, présentant rectorragie, ténesmes, épreintes 6 mois après un…”
Get full text
Journal Article -
11
Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 – REGOLD
Published in Journal of geriatric oncology (01-11-2020)“…Regorafenib significantly increases overall survival (OS) in patients with metastatic colorectal cancer previously treated but gives toxicities. to assess the…”
Get full text
Journal Article -
12
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial
Published in JAMA oncology (01-11-2022)“…Early results at 3 years from the PRODIGE 24/Canadian Cancer Trials Group PA6 randomized clinical trial showed survival benefits with adjuvant treatment with…”
Get more information
Journal Article -
13
Adapted physical activity in patients (Pts) with advanced pancreatic cancer (APACaP): Results from a prospective national randomized GERCOR trial
Published in Journal of clinical oncology (01-06-2022)“…4007 Background: The benefit of adapted physical activity (APA) on health-related quality of life (HRQoL) in Pts with advanced pancreatic ductal adenocarcinoma…”
Get full text
Journal Article -
14
Quality of Life in Cancer Patients Undergoing Anticoagulant Treatment for Venous Thromboembolism: The Quavitec Study
Published in Blood (02-12-2016)“…Introduction: Treatment and prevention of VTE is crucial, yet anticoagulation is under-prescribed in cancer patients. The recommended treatment for established…”
Get full text
Journal Article -
15
Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC)
Published in Oncotarget (05-06-2018)“…Clinical guidelines recommend at least 3-months low molecular weight heparin (LMWH) treatment for established venous thromboembolism (VTE) in cancer patients…”
Get full text
Journal Article -
16
-
17
-
18
Ano-rectal symptoms, related to Epstein-Barr Virus-Associated Burkitt's lymphoma in an immunocompetent patient
Published in Gastroentérologie clinique et biologique (01-04-2007)“…We report the case of an immunocompetent 23-year-old Caucasian woman, with symptoms including rectal bleeding, tenesmus and epreint, 6 months after an anal…”
Get full text
Journal Article -
19
Ano-rectal symptoms, related to Epstein-Barr Virus-Associated Burkitt's lymphoma in an immunocompetent patient
Published in Gastroentérologie clinique et biologique (01-04-2007)Get full text
Journal Article